Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

AltaRex establishes joint venture for OvaRex

July 6, 2000

Antigenics commences first phase III trial of its Oncophage cancer vaccine

July 6, 2000

Biomira acquires remaining rights to Theratope from Chiron

July 4, 2000

Cancer immunotherapies based on WT-1 and gata-1 peptide epitopes

July 4, 2000

Cel-Sci receives permission to start phase II cancer trial in Canada

June 30, 2000

StressGen's HspE7 advances to phase III trials in anal dysplasia

June 28, 2000

FDA completes initial review of BLA for Campath

June 28, 2000

Lorus Therapeutics reports strong meta-analysis results for Virulizin, prepares for phase III trials

June 28, 2000

Tumor-associated antigen-derived immunogenic polypeptides useful for cancer immunotherapy

June 23, 2000

Mylotarg now available in U.S. as treatment for relapsed AML

June 22, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...